USFDA approves intramuscular administration for Merck’s MMRV family of vaccines
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Rocuronium Bromide Injection is a neuromuscular blocking agent
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
he product will be launched shortly in the US market.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Subscribe To Our Newsletter & Stay Updated